Is Haemophilus influenzae type b disease finished?

Advances in Experimental Medicine and Biology

Volumn 549, Issue , 2004, Pages 221-229

  Kelly, Dominic ^a   Moxon, E Richard ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DIPHTHERIA TOXOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HBOC VACCINE; OUTER MEMBRANE PROTEIN; PERTUSSIS VACCINE; POLYRIBOSYLRIBITOL PHOSPHATE; POLYSACCHARIDE VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; CLINICAL TRIAL; DRUG EFFICACY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM; VACCINATION;

BACTERIA (MICROORGANISMS); HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE SEROTYPE B;

EID: 3242776227     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-8993-2_29     Document Type: Review

References (36)

1. Alexander, H., Heidelberger M., and Leidy, G. (1944). The protective or curative element in type B H. influenzae rabbit serum. Yale J. Biol. Med. 16, 425-440.
2. Anderson, P. (1983). Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197. Infect. Immun. 39(1), 233-238.
3. Anderson, P., Ingram, D.L., Pichichero, M.E., and Peter, G. (2000). A high degree of natural immunologic priming to the capsular polysaccharide may not prevent Haemophilus influenzae type b meningitis. Pediatr. Infect. Dis. J. 19(7), 589-591.
4. Avery, O. and Goebel, W.T. (1929). Chemo-immunological studies on conjugated carbohydrate-proteins: II. Immunological specificity of synthetic sugar-protein antigens. J. Exp. Med. 50, 522-550.
5. Booy, R., Moxon, E.R., MacFarlane, J.A., Mayon-White, R.T., and Slack, M.P. (1992). Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford region. Lancet 340(8823), 847.
6. Cadoz, M. (1998). Potential and limitations of polysaccharide vaccines in infancy. Vaccine 16(14-15), 1391-1395.
7. Decker, M.D., Edwards, K.M., Bradley, R., and Palmer, P. (1992). Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J. Pediatr. 120(2 Pt 1), 184-189.
8. Englund, J.A. and Glezen, W.P. (2003). Maternal immunization with Haemophilus influenzae type b vaccines in different populations. Vaccine 21(24), 3455-3459.
9. Eskola, J., Peltola, H., Takala, A.K., Kayhty, H., Hakulinen, M., Karanko, V. et al. (1987). Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N. Engl. J. Med. 317(12), 717-722.
10. Eskola, J., Ward, J., Dagan, R., Goldblatt, D., Zepp, F., and Siegrist, C.A. (1999). Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 354(9195), 2063-2068.
11. Galil, K., Singleton, R., Levine, O.S., Fitzgerald, M.A., Bulkow, L., Getty, M. et al. (1999). Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J. Infect. Dis. 179(1), 101-106.
12. Granoff, D.M., Holmes, S.J., Osterholm, M.T., McHugh, J.E., Lucas, A.H., Anderson, E.L. et al. (1993). Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J. Infect. Dis. 168(3), 663-671.
13. Health Protection Agency. Laboratory reports of Haemophilus influenzae type B infection by age group and quarter: England and Wales: 1990-2003 (30 April 2003), http://www.hpa.org.uk/infections/topics_az/ haemophilus_influenzae/ data_lab_age_qtr.htm.
14. Heath, P.T. and Ramsay, M.E. (2003). Haemophilus influenzae type b vaccine - booster campaign. BMJ 320(7400), 1158-1159.
15. HPA (2003). Immunisation archive 2003. Laboratory reports of Haemophilus influenzae by age group and serotype England and Wales. CDR Weekly, 1.
16. Kayhty, H., Eskola, J., Peltola, H., Saarinen, L., and Makela, RH. (1992). High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines. J. Infect. Dis. 165(Suppl 1), S165-S166.
17. Kayhty, H., Karanko, V., Peltola, H., and Makela, RH. (1984). Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: No evidence of immunologic tolerance or memory. Pediatrics 74(5), 857-865.
18. Kroll, J.S. and Moxon, E.R. (1990). Capsulation in distantly related strains of Haemophilus influenzae type b: Genetic drift and gene transfer at the capsulation locus. J. Bacteriol. 172(3), 1374-1379.
19. Lucas, A.H. and Granoff, D.M. (2001). Imperfect memory and the development of Haemophilus influenzae type B disease. Pediatr. Infect. Dis. J. 20(3), 235-239.
20. Makela, P.H. and Kayhty, H. (2002). Evolution of conjugate vaccines. Expert Rev. Vaccines 1(3), 399-410.
21. McVernon, J., Andrews, N., Slack, M.P., and Ramsay, M.E. (2003a). Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet 361(9368), 1521-1523.
22. McVernon, J., Johnson, P.D., Pollard, A.J., Slack, M.P., and Moxon, E.R. (2003b). Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure. Arch. Dis. Child. 88(5), 379-383.
23. Mulholland, K., Hilton, S., Adegbola, R., Usen, S., Oparaugo, A., Omosigho, C. et al. (1997). Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. Lancet 349(9060), 1191-1197.
24. Murphy, T.V., Pastor, P., Medley, F., Osterholm, M.T., and Granoff, D.M. (1993). Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J. Pediatr. 122(4), 517-523.
25. Parke, J.C., Jr., Schneerson, R., Robbins, J.B., and Schlesselman, J.J. (1977). Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974 to March 1976). J. Infect. Dis. 136(Suppl), S51-S56.
26. Peltola, H., Kayhty, H., Sivonen, A., and Makela, H. (1977). Haemophilus influenzae type b capsular polysaccharide vaccine in children: A double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 60(5), 730-737.
27. Schneerson, R., Barrera, O., Sutton, A., and Robbins, J.B. (1980). Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J. Exp. Med. 152(2), 361-376.
28. Siber, G.R. (1994). Pneumococcal disease: Prospects for a new generation of vaccines. Science 265(5177), 1385-1387.
29. Siegrist, C.A. (2003). Mechanisms by which maternal antibodies influence infant vaccine responses: Review of hypotheses and definition of main determinants. Vaccine 21(24), 3406-3412.
30. Smith, D.H., Peter, G., Ingram, D.L., Harding, A.L., and Anderson, P. (1973). Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics 52(5), 637-644.
31. Swartley, J.S., Marfin, A.A., Edupuganti, S., Liu, L.J., Cieslak, P., Perkins, B. et al. (1997). Capsule switching of Neisseria meningitidis. Proc. Natl. Acad. Sci. USA 94(1), 271-276.
32. Takala, A.K., Eskola, J., Leinonen, M., Kayhty, H., Nissinen, A., Pekkanen, E. et al. (1991). Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J. Infect. Dis. 164(5), 982-986.
33. Trotter, C.L., McVernon, J., Andrews, N.J., Burrage, M., and Ramsay, M.E. (2003). Antibody to Haemophilus influenzae type b after routine and catch-up vaccination. Lancet 361(9368), 1523-1524.
34. Vadheim, C.M., Greenberg, D.P., Partridge, S., Jing, J., and Ward, J.I. (1993). Effectiveness and safety of an Haemophilus influenzae type b conjugate vaccine (PRP-T) in young infants. Kaiser-UCLA Vaccine Study Group. Pediatrics 92(2), 272-279.
35. Weinberg, G.A., Einhorn, M.S., Lenoir, A.A., Granoff, P.D., and Granoff, D.M. (1987). Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide - Neisseria meningitidis outer membrane protein conjugate vaccine. J. Pediatr. 111(1), 22-27.
36. Wenger, J.D., Booy, R., Heath, P., and Moxon, E.R. (1997) Epidemiological impact of conjugate vaccines on invasive disease caused by Haemophilus influenzae type b. In M.M. Levine, G.C. Woodrow, J.B. Kaper, and G.S. Cobon (eds.), New Generation Vaccines, 2nd edn. Marcel Dekker Inc, New York, pp. 489-502.